Review article: anti-adhesion therapies for inflammatory bowel disease.

@article{Lobatn2014ReviewAA,
  title={Review article: anti-adhesion therapies for inflammatory bowel disease.},
  author={Triana Lobat{\'o}n and S{\'e}verine Vermeire and Gert Van Assche and P. R. Rutgeerts},
  journal={Alimentary pharmacology & therapeutics},
  year={2014},
  volume={39 6},
  pages={579-94}
}
BACKGROUND A high proportion of patients with inflammatory bowel disease (IBD) do not achieve clinical remission with the current therapies including mesalazine (mesalamine), immunossupresants (IMS) and antibodies against tumour necrosis factor (anti-TNF). Moreover, IMS and anti-TNF involve a nonnegligible risk for infections and/or malignancies. The anti-adhesion molecules are one of the most interesting new treatments because of their gut-selectivity. AIM To review the physiopathology of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 109 references

Decrease in the numbers of dendritic cells and CD4 + T cells in cerebral perivascular spaces due to 592 Aliment

  • M Del Pilar Martin, PD Cravens, R Winger
  • Pharmacol Ther
  • 2014

Similar Papers

Loading similar papers…